COR VS BDX Stock Comparison

PerformanceAnalyst Price TargetsEarningsProfitVolatilityDividendTechnicals
PerformanceAnalyst Price TargetsEarningsProfitVolatilityDividendTechnicals

Performance

COR
100/100

COR returned 7.05% in the last 12 months. Based on SPY's performance of -13.80%, its performance is above average giving it a score of 100 of 100.

BDX
100/100

BDX returned 4.47% in the last 12 months. Based on SPY's performance of -13.74%, its performance is above average giving it a score of 100 of 100.

Analyst Price Targets

COR
68/100

15 analysts offer 12-month price targets for COR. Together, they have an average target of 171, the most optimistic target put COR at 190 within 12-months and the most pessimistic has COR at 150.

BDX
78/100

15 analysts offer 12-month price targets for BDX. Together, they have an average target of 276, the most optimistic target put BDX at 295 within 12-months and the most pessimistic has BDX at 250.

Earnings

COR
100/100

COR has missed earnings 1 times in the last 20 quarters.

BDX
100/100

BDX has missed earnings 0 times in the last 20 quarters.

Profit

COR
84/100

Out of the last 20 quarters, COR has had 20 profitable quarters and has increased their profits year over year on 12 of them.

BDX
80/100

Out of the last 20 quarters, BDX has had 20 profitable quarters and has increased their profits year over year on 9 of them.

Volatility

COR
55/100

COR has had a higher than average amount of volatility over the last 12 months giving it a score of 55 of 100.

BDX
48/100

BDX has had a lower than average amount of volatility over the last 12 months giving it a score of 47 of 100.

Dividend

COR
10/100

COR's most recent dividend was $0.81 per share, based on a share price of $193.22. It was a payout ratio of 182.09% compared to their total earnings.

BDX
10/100

BDX's most recent dividend was $0.87 per share, based on a share price of $233.76. It was a payout ratio of -139.53% compared to their total earnings.

Technicals

COR

"Technicals" not found for COR

BDX
14/100

BDX receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.

All score calculations are broken down here to help you make more informed investing decisions

Cencora, Inc. Summary

New York Stock Exchange / COR
Healthcare
Medical - Distribution
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Becton, Dickinson and Co. Summary

New York Stock Exchange / BDX
Healthcare
Medical - Instruments & Supplies
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.